Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Innovative Pharmaceutical Biotech ( (HK:0399) ) has provided an update.
Innovative Pharmaceutical Biotech Limited announced the extension of long stop dates for its subscription agreements with Zhang Biaobing and Chen Jing. The extension, from August 5, 2025, to August 26, 2025, allows additional time to fulfill conditions precedent, ensuring the continuation of the agreements’ terms and conditions. This move reflects the company’s strategic efforts to secure necessary capital while maintaining its operational commitments.
More about Innovative Pharmaceutical Biotech
Innovative Pharmaceutical Biotech Limited operates in the pharmaceutical and biotechnology industry, focusing on the development and commercialization of innovative medical solutions. The company is listed on the Hong Kong Stock Exchange and engages in activities related to drug discovery and development.
Average Trading Volume: 18,368,653
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.14B
For an in-depth examination of 0399 stock, go to TipRanks’ Overview page.